Skip to main content
. Author manuscript; available in PMC: 2014 Mar 15.
Published in final edited form as: J Neuroimmunol. 2013 Feb 4;256(0):38–42. doi: 10.1016/j.jneuroim.2013.01.002

Figure 1.

Figure 1

Relationship of plasma MCP-1 levels to macrophage activation/differentiation defined by CD14 co-expression of CD16 in elderly controls and patients with early stages of AD. Positive correlation of plasma MCP-1 levels with degree of CD16 expression on CD14+ monocyte in early AD (r = 0.5006, p = 0.0127, n = 24).